Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Establishing Capabilities to Build Customer Commitment and Market Share

Marketing Capability Development - by Bayer Russia with support from Ashfield Insight &Performance.

Roche’s Tecentriq/Avastin combo improves survival in liver cancer

Roche’s Tecentriq/Avastin combo improves survival in liver cancer death by 42% compared to Bayer’s Nexavar (sorafenib) when given as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for surgery. ... able to achieve a significant improvement over Bayer’s drug on overall survival.

Sanofi said to be looking at options for $30bn consumer health unit

Sanofi said to be looking at options for $30bn consumer health unit Many have decided either to sell off the divisions in whole or in part – including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example – while GlaxoSmithKline and Pfizer both slimmed

Bayer, Merck’s high-risk heart failure drug comes good in phase 3

Bayer, Merck’s high-risk heart failure drug comes good in phase 3 Significantly reduced the risk of hospitalisation or cardiovascular death. Bayer and Merck &Co/MSD raised some eyebrows three years ago when they started a phase 3 programme for chronic heart failure ... The top-line readout suggests Merck and Bayer’s

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer Bayer’s Nexavar (sorafenib).

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics